Achieve Life Sciences (ACHV) Other financing activities (2020 - 2025)
Achieve Life Sciences (ACHV) recorded quarterly Other financing activities of $3.8 million in Q2 2025, up 18900.0% on a QoQ basis from $20000.0 in Q1 2022.
Achieve Life Sciences (ACHV) Other financing activities (2020 - 2025) Analysis & Trends
Achieve Life Sciences has disclosed Other financing activities across 3 years of filings, most recently posting $3.8 million for Q2 2025.
- Quarterly Other financing activities changed N/A year-over-year to $3.8 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $3.8 million (changed N/A YoY) and the FY2022 annual result came in at $20000.0, changed N/A from the prior year.
- Other financing activities advanced to $3.8 million in Q2 2025, from $20000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $3.8 million in Q2 2025 and troughed at $20000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3.80 Mn |
| Jun 30, 2025 | 3.80 Mn |
| Mar 31, 2022 | 20,000.00 |
| Mar 31, 2022 | 20,000.00 |
| Jun 30, 2020 | -20,000.00 |
| Jun 30, 2020 | -20,000.00 |
| Mar 31, 2020 | 34,000.00 |
| Mar 31, 2020 | 34,000.00 |